Compare Stocks → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EYEBATS:PBEENASDAQ:SAASTSE:SYZ Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYENational Vision$18.78+0.3%$21.38$13.71▼$27.02$1.47B1.39968,261 shs614,208 shsPBEEInvesco PureBeta FTSE Emerging Markets ETF$22.40$22.39$24.50▼$28.85$15.68M0.63N/A206 shsSAAS(SAAS)$0.01$0.00$7.15▼$13.99N/AN/A1.05 million shs200,000 shsSYZSylogistC$9.06-2.7%C$8.95C$5.40▼C$9.96C$212.64M0.8456,121 shs63,521 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYENational Vision-1.37%-4.68%-17.42%-3.26%-6.68%PBEEInvesco PureBeta FTSE Emerging Markets ETF0.00%0.00%0.00%0.00%-1.57%SAAS(SAAS)0.00%0.00%0.00%0.00%0.00%SYZSylogist-2.62%-5.96%+7.01%+29.49%+55.17%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEYENational Vision3.2782 of 5 stars3.02.00.03.31.20.01.9PBEEInvesco PureBeta FTSE Emerging Markets ETFN/AN/AN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/AN/AN/ASYZSylogist1.0227 of 5 stars3.50.00.00.01.80.00.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYENational Vision2.00Hold$23.8627.03% UpsidePBEEInvesco PureBeta FTSE Emerging Markets ETF0.00N/AN/AN/ASAAS(SAAS)N/AN/AN/AN/ASYZSylogist3.00BuyC$11.5026.93% UpsideCurrent Analyst RatingsLatest PBEE, SYZ, DEV, SAAS, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/15/2024SYZSylogistEchelon Wealth PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuyC$11.00 ➝ C$12.503/15/2024SYZSylogistCormarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetC$10.50 ➝ C$11.002/28/2024EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$18.00 ➝ $20.002/14/2024SYZSylogistParadigm CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$12.002/1/2024SYZSylogistStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$14.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYENational Vision$2.13B0.69$1.74 per share10.78$10.60 per share1.77PBEEInvesco PureBeta FTSE Emerging Markets ETFN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/ASYZSylogistC$65.51M3.25C$1.29 per share7.02C$1.60 per share5.66Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYENational Vision-$65.90M-$0.85N/A39.964.27-3.10%3.69%1.41%5/9/2024 (Estimated)PBEEInvesco PureBeta FTSE Emerging Markets ETFN/AN/A15.21∞N/AN/AN/AN/AN/ASAAS(SAAS)N/AN/A0.00∞N/AN/AN/AN/AN/ASYZSylogistC$1.10MC$0.05181.20∞N/A1.68%2.84%3.56%5/9/2024 (Estimated)Latest PBEE, SYZ, DEV, SAAS, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/14/2024Q4 2023SYZSylogistC$0.05C$0.01-C$0.04C$0.01C$16.43 millionC$16.17 million2/27/202412/31/2023EYENational Vision-$0.09-$0.02+$0.07$0.06$499.49 million$506.40 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYENational VisionN/AN/AN/AN/AN/APBEEInvesco PureBeta FTSE Emerging Markets ETFN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/ASYZSylogistC$0.040.44%N/A80.00%N/ALatest PBEE, SYZ, DEV, SAAS, and EYE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/16/2024SYZSylogistQuarterlyC$0.010.43%2/28/20242/29/20243/13/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYENational Vision0.541.000.70PBEEInvesco PureBeta FTSE Emerging Markets ETFN/AN/AN/ASAAS(SAAS)N/AN/AN/ASYZSylogist47.190.540.51OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYENational VisionN/APBEEInvesco PureBeta FTSE Emerging Markets ETFN/ASAAS(SAAS)93.53%SYZSylogist26.50%Insider OwnershipCompanyInsider OwnershipEYENational Vision2.10%PBEEInvesco PureBeta FTSE Emerging Markets ETFN/ASAAS(SAAS)6.30%SYZSylogist5.16%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEYENational Vision13,99878.31 million76.67 millionOptionablePBEEInvesco PureBeta FTSE Emerging Markets ETFN/A700,000N/ANot OptionableSAAS(SAAS)N/AN/AN/ANot OptionableSYZSylogistN/A23.47 millionN/ANot OptionablePBEE, SYZ, DEV, SAAS, and EYE HeadlinesSourceHeadlineEchelon Wealth Partners Brokers Cut Earnings Estimates for Sylogist Ltd. (TSE:SYZ)americanbankingnews.com - April 17 at 1:22 AMYou haven’t missed the boat on Sylogist, Echelon sayscantechletter.com - April 16 at 12:42 PMSylogist Ltd. Expected to Post Q1 2024 Earnings of $0.04 Per Share (TSE:SYZ)marketbeat.com - April 16 at 7:27 AMSylogist (TSE:SYZ) Given New C$12.50 Price Target at Echelon Wealth Partnersamericanbankingnews.com - April 16 at 3:50 AMEchelon Wealth Partners Boosts Sylogist (TSE:SYZ) Price Target to C$12.50marketbeat.com - April 15 at 2:24 PMSylogist (TSE:SYZ) Hits New 12-Month High at $9.90marketbeat.com - April 11 at 3:20 PMEchelon Wealth Partners Research Analysts Lower Earnings Estimates for Sylogist Ltd. (TSE:SYZ)marketbeat.com - April 5 at 8:52 AMSylogist (TSE:SYZ) Sets New 52-Week High at $9.40marketbeat.com - April 4 at 6:20 PMGot $5,000? 5 Stocks to Buy for Lasting Wealthmsn.com - March 29 at 6:36 PMSylogist Full Year 2023 Earnings: EPS Misses Expectationsfinance.yahoo.com - March 20 at 3:45 PMSylogist Ltd.wsj.com - March 15 at 2:40 PMSylogist earns target raise at Paradigmcantechletter.com - March 15 at 2:40 PMSylogist (TSE:SYZ) Could Be Struggling To Allocate Capitalfinance.yahoo.com - March 14 at 12:42 PMSylogist Ltd.: Sylogist Reports Record Fourth Quarter and Full Year 2023 Resultsfinanznachrichten.de - March 14 at 8:12 AMSYZ stock is a buy, Echelon sayscantechletter.com - February 27 at 1:28 PMAnalysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Indextheglobeandmail.com - February 21 at 6:50 PMHere's How a Strategy Shift Impacted Sylogist (SYZLF)msn.com - February 5 at 7:33 PMGreystone Capital Q4 2023 Letter To Clientsseekingalpha.com - February 3 at 8:38 AMPubtech Assertive Yield Targets 2X Growth in 2024 After Hitting $750M Traded Revenue Milestone in 2023theglobeandmail.com - February 2 at 11:02 PMSylogist initiated with bullish view at Stifel, here's whyrealmoney.thestreet.com - January 31 at 10:45 PMSylogist Ltd. (TSE:SYZ) Shares Could Be 48% Below Their Intrinsic Value Estimatefinance.yahoo.com - January 25 at 6:04 AMShiraz Airport, Shiraz, Iran [ SYZ / OISS ]prokerala.com - January 20 at 6:36 PMShareholders in Sylogist (TSE:SYZ) are in the red if they invested five years agofinance.yahoo.com - December 15 at 12:40 PMCanaccord Genuity Believes Sylogist (SYZ) Still Has Room to Growmarkets.businessinsider.com - November 11 at 12:28 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesNvidia's AI Tech Part of Novo Nordisk's New Supercomputer March 24, 2024 1:50 PMView Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer Google and Meta Circling the Market on a TikTok Ban RallyMarch 21, 2024 12:58 PMView Google and Meta Circling the Market on a TikTok Ban Rally2 Data Storage Device Stocks Thriving From the AI BoomApril 2, 2024 7:25 AMView 2 Data Storage Device Stocks Thriving From the AI BoomAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentDexCom Stock Gains from GLP-1 Diabetic UsersApril 2, 2024 7:16 AMView DexCom Stock Gains from GLP-1 Diabetic UsersAll Headlines Company DescriptionsNational VisionNASDAQ:EYENational Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Invesco PureBeta FTSE Emerging Markets ETFBATS:PBEEThe Invesco PureBeta FTSE Emerging Markets ETF (PBEE) is an exchange-traded fund that is based on the FTSE All-World Emerging index. The fund tracks a market cap-weighted index of large- and mid-cap emerging-market companies. PBEE was launched on Sep 22, 2017 and is managed by Invesco.(SAAS)NASDAQ:SAASinContact, Inc. (inContact) is a provider of cloud contact center software solutions. The Company provides a range of cloud contact center call routing, self-service and agent optimization solutions. The Company operates through two business segments: Software and Network connectivity. inContact's Software segment includes the services related to the delivery of its cloud contact center software solutions. Its Network connectivity segment includes the voice and data long distance services provided to customers. It offers its products and services to its customers in approximately five vertical markets, such as customer services and sales business process outsourcers (BPOs), retail and direct response, healthcare providers, utilities, and state and local Government. It provides software, which includes Automatic call distributing, Computer telephony integration, Interactive voice response with speech recognition, Outbound dialer, Screen recording and Interactive reporting tool.SylogistTSE:SYZSylogist Ltd., a software company, provides software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company manages IT services, business applications, and Web portals. The company was incorporated in 1993 and is headquartered in Calgary, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.